Evidence map›Paper›PMID 34342849›Full record

ArticleCNS drugs2021

Correction to: Effect of Enzyme‑Inducing Antiseizure Medications on the Risk of Sub‑Therapeutic Concentrations of Direct Oral Anticoagulants: A Retrospective Cohort Study.

Amichai Perlman, Rachel Goldstein, Lotan Choshen Cohen, Bruria Hirsh-Raccah, David Hakimian, Ilan Matok, Yosef Kalish, Daniel E Singer, Mordechai Muszkat

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in CNS drugs, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors.

Amichai Perlman *Department of Medicine, Hadassah Hebrew University Medical Center, Mount Scopus, 91540, Jerusalem, Israel.
Rachel Goldstein *Department of Medicine, Hadassah Hebrew University Medical Center, Mount Scopus, 91540, Jerusalem, Israel.
Lotan Choshen CohenDepartment of Medicine, Hadassah Hebrew University Medical Center, Mount Scopus, 91540, Jerusalem, Israel.
Bruria Hirsh-RaccahDepartment of Pharmacy, Hadassah Hebrew University Medical Center, Jerusalem, Israel.
David HakimianDepartment of Medicine, Hadassah Hebrew University Medical Center, Mount Scopus, 91540, Jerusalem, Israel.
Ilan MatokDivision of Clinical Pharmacy, Faculty of Medicine, Institute for Drug Research, School of Pharmacy, Hebrew University of Jerusalem, Jerusalem, Israel.
Yosef KalishDepartment of Hematology, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.
Daniel E SingerDivision of General Internal Medicine, Massachusetts General Hospital, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
Mordechai MuszkatDepartment of Medicine, Hadassah Hebrew University Medical Center, Mount Scopus, 91540, Jerusalem, Israel. muszkatm@hadassah.org.il.ORCID https://orcid.org/0000-0002-9520-1379

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID34342849
PMCPMC8496610

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.